The virtual screening for potential allosteric inhibitors targeting PIF-pocket of MAST protein kinases
Abstract
Aim. The objective of current study was the virtual screening for potential allosteric inhibitors of MAST protein kinases, as well as revision of their isotype-specific potential. Methods. Literature and database search. Molecular modeling, pharmacophore screening, artificial intelligence, molecular docking, etc. Results. Based on pharmacophore screening of Enamine Ltd chemical space, 23 potential effectors of the PIF site of MAST protein kinases were selected. Based on AI reconstruction of protein-ligand complexes, the ATP-, PIF- and K-sites of MAST protein kinases where predict for potential binding of selected compounds. Subsequent CCDC GOLD molecular docking, identify the PIF-pocket as the priory site for selected compounds binding, and the leaders of screening where selected. Conclusions. Based on the complex protocol of Enamine Ltd. (4,117,328 compounds/60,516,302 conformers) chemical space virtual screening, 23 perspective PIF-site specific inhibitors of MAST protein kinases were selected. The possibility of isotype-specific inhibition of representatives of the MAST family was revealed. The leading compounds were selected for further combinatorial design and laboratory testing.
References
Rumpf M., Pautz S., Drebes B. et al. Microtubule-Associated Serine/Threonine (MAST) kinases in development and disease. International Journal of Molecular Sciences. 2023. Vol. 24 (15). P. 11913. https://doi.org/10.3390/ijms241511913.
Chudinova E. M., Karpov P. A., Fokin A. I. et al. MAST-like protein kinase IREH1 from Arabidopsis thaliana co-localizes with the centrosome when expressed in animal cells. Planta. 2017. Vol. 246 (5). P. 959–969. https://doi.org/10.1007/s00425-017-2742-4.
Pearce L. R., Komander D., Alessi D. R. The nuts and bolts of AGC protein kinases. Nature Reviews Molecular Cell Biology. 2009. Vol. 11 (1). P. 9–22. https://doi.org/10.1038/nrm2822.
Thaimattam R., Banerjee R., Miglani R., Iqbal J. Protein kinase Inhibitors: Structural Insights into Selectivity. Current Pharma-ceutical Design. 2007. 13 (27). P. 2751–2765. https://doi.org/10.2174/138161207781757042.
Karpov P. A., Steshenko A. O., Ozheredov S. P., Blume Y. B. Prediction of protein-ligand binding sites modulating activity of MAST protein kinases. Faktori Eksperimentalnoi Evolucii Organizmiv. 2024. Vol. 35. P. 151–157. https://doi.org/10.7124/feeo.v35.1677.
Jester B. W., Gaj A., Shomin C. D. et al. Testing the promiscuity of commercial kinase inhibitors against the AGC kinase group using a split-luciferase screen. Journal of Medicinal Chemistry. 2012. Vol. 55 (4). P. 1526–1537. https://doi.org/10.1021/jm201265f.
Engel M. The PIF pocket of AGC kinases: a target site for allosteric modulators and Protein–Protein interaction inhibitors. Meth-ods and Principles in Medicinal Chemistry. 2013. P. 187–223. https://doi.org/10.1002/9783527648207.ch9.
Busschots K., Lopez-Garcia L.A., Lammi C. et al. Substrate-Selective Inhibition of Protein Kinase PDK1 by Small Compounds that Bind to the PIF-Pocket Allosteric Docking Site. Chemistry & Biology. 2012. Vol. 19 (9). P. 1152–1163. https://doi.org/10.1016/j.chembiol.2012.07.017.
Busschots K., Lopez-Garcia L. A., Lammi C. et al. Substrate-Selective Inhibition of Protein Kinase PDK1 by Small Compounds that Bind to the PIF-Pocket Allosteric Docking Site. Chemistry & Biology. 2012. Vol. 19 (9). P. 1152–1163. https://doi.org/10.1016/j.chembiol.2012.07.017.